Translational Development Acquisition Corp. (TDAC)
NASDAQ: TDAC · Real-Time Price · USD
10.11
0.00 (0.00%)
Apr 24, 2025, 4:00 PM EDT - Market closed

TDAC Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Net Income
-0.07-0.49-0.07
Other Amortization
-0.48-
Other Operating Activities
-0.12--
Change in Accounts Payable
-0.450-
Change in Other Net Operating Assets
-0.210-0.08
Operating Cash Flow
-0.85-0-0.15
Other Investing Activities
-174.23--
Investing Cash Flow
-174.23--
Long-Term Debt Issued
0.41--
Total Debt Issued
0.41-0.34
Long-Term Debt Repaid
-0.8--
Net Debt Issued (Repaid)
-0.39-0.34
Issuance of Common Stock
169.05-0.04
Other Financing Activities
6.86--0.23
Financing Cash Flow
175.51-0.15
Net Cash Flow
0.44-00
Levered Free Cash Flow
-0.290.19-
Unlevered Free Cash Flow
-0.29-0.29-
Change in Net Working Capital
0.16-0.01-
Updated Nov 20, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q